Heart drug dosing study aims to help kids with duchenne
Knowledge-focused
Not yet recruiting
This study looks at how the heart medication empagliflozin is processed in children with Duchenne muscular dystrophy (DMD) who have early heart damage. Researchers will give different doses to 10 children aged 8 to 18 and measure drug levels in their blood over 24 hours. The goal…
Phase: PHASE1 • Sponsor: Larry W. Markham • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC